SSA
BCYC

Schonfeld Strategic Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,500
Closed -$595K – 2206
2024
Q4 		$595K Sell
42,500
-380,500
-90% -$8.15M ﹤0.01% 1322
2024
Q3 		$9.57M Buy
423,000
+265,562
+169% +$6.13M 0.06% 312
2024
Q2 		$3.19M Sell
157,438
-263,362
-63% -$5.95M 0.02% 708
2024
Q1 		$10.5M Buy
420,800
+313,800
+293% +$6.67M 0.07% 360
2023
Q4 		$1.93M Buy
107,000
+54,900
+105% +$908K 0.01% 810
2023
Q3 		$1.05M Sell
52,100
-14,000
-21% -$320K 0.01% 1007
2023
Q2 		$1.69M Buy
66,100
+6,000
+10% +$139K 0.01% 803
2023
Q1 		$1.28M Sell
60,100
-19,646
-25% -$493K 0.01% 853
2022
Q4 		$2.36M Buy
79,746
+58,946
+283% +$1.58M 0.02% 759
2022
Q3 		$483K Sell
20,800
-500
-2% -$11.9K ﹤0.01% 1778
2022
Q2 		$358K Buy
21,300
+13,300
+166% +$280K ﹤0.01% 1554
2022
Q1 		$351K Buy
+8,000
New +$374K ﹤0.01% 1583
2021
Q4 		– Sell
-59,972
Closed -$2.49M – 2148
2021
Q3 		$2.49M Buy
59,972
+5,110
+9% +$179K 0.03% 641
2021
Q2 		$1.67M Buy
54,862
+43,762
+394% +$1.32M 0.02% 770
2021
Q1 		$331K Buy
+11,100
New +$286K ﹤0.01% 1298

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Schonfeld Strategic Advisors's BCYC Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 42,500 shares — an estimated $595K sold.

Schonfeld Strategic Advisors first reported a position in BCYC in Q1 2021 and held it in 15 quarters. The position peaked at $10.5M in Q1 2024. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 42,500 Bicycle Therapeutics shares in Q1 2025, an estimated $595K.
  • Schonfeld Strategic Advisors first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 15 quarters.
  • Schonfeld Strategic Advisors's Bicycle Therapeutics position peaked at $10.5M in Q1 2024.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.